FAIRCHEM ORGANICS LIMITED
FAIRCHEMOR · General/Diversified · NSE
₹558
Current Market Price
Fair Value (DCF)
₹202
Margin of Safety
-63.8%
Updated 6h ago
YieldIQ Score
9/100
Piotroski F-Score
2/9
Economic Moat
None
Confidence
33%
ROE
—
Debt/Equity
0.19
WACC
11.1%
Market Cap
₹702 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.4%
Return on capital employed
EV / EBITDA
45.4×
Enterprise multiple
Debt / EBITDA
3.5×
Leverage vs earnings
Interest Coverage
9.2×
EBIT covers interest
Current Ratio
2.30×
Short-term liquidity
Asset Turnover
1.33×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-5.8%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹557.5
Bear case
₹127.26
MoS -338.1%
Base case
₹201.68
MoS -176.4%
Bull case
₹300.42
MoS -85.6%
Ratio Trends
FAIRCHEMOR · last 5 annual periods
ROE
7.3%
ROCE
12.1%
Operating Margin
—
Debt / Equity
0.21×
PE
97.0×
EV / EBITDA
16.4×
Historical Financials
FAIRCHEMOR · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹397 Cr | ₹643 Cr | ₹646 Cr | ₹618 Cr | ₹536 Cr | +7.8% |
| EBITDA | — | ₹105 Cr | ₹73.0 Cr | ₹68.1 Cr | ₹44.1 Cr | -19.5% |
| EBIT | ₹62.4 Cr | ₹98.1 Cr | ₹17.3 Cr | ₹16.5 Cr | — | -28.3% |
| PAT | ₹42.5 Cr | ₹67.9 Cr | ₹43.5 Cr | ₹40.5 Cr | ₹22.0 Cr | -15.2% |
| EPS (diluted) | ₹32.63 | ₹52.15 | ₹9.11 | ₹9.03 | — | -27.5% |
| CFO | ₹39.4 Cr | ₹40.5 Cr | ₹49.6 Cr | ₹74.5 Cr | ₹-16.8 Cr | — |
| CapEx | — | — | — | — | ₹-26.1 Cr | — |
| FCF | — | — | — | — | ₹-42.9 Cr | — |
| Total Assets | — | ₹324 Cr | ₹342 Cr | ₹334 Cr | ₹402 Cr | +5.5% |
| Total Debt | — | — | ₹50.2 Cr | ₹7.3 Cr | ₹63.0 Cr | +5.9% |
| Shareholders' Equity | — | — | ₹259 Cr | ₹290 Cr | ₹302 Cr | +3.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
FAIRCHEMOR vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BHAGERIA BHAGERIA | — | — | Pending | 7.3% | — |
| GANESHBE GANESH BENZOPLAST LIMITED | +16.7% | 45 | Undervalued | 7.0% | — |
| AGARIND AGARWAL INDS CORP LTD. | -15.3% | 51 | Overvalued | 18.4% | — |
| KOTHARIPET KOTHARI PETROCHEM LTD | +53.9% | 60 | Undervalued | 21.5% | — |
| TNPETRO TNPETRO | — | — | Pending | 6.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for FAIRCHEMOR in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of FAIRCHEMOR →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for FAIRCHEMOR →
Compare
Head-to-head with peers
Compare FAIRCHEMOR side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse FAIRCHEMORNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.